Levine James E.

Insider profile

Performance

Overall performance
3.3

Performance over holding periods
3.3
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
11 100% Buy
34 71% Buy
47 69% Buy
Levine James E.'s trades of Cardiff Oncology Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-18 2024-12-18 B Purchase
85,591 +13.4%
352.45
US$3,551,110
85,591 +13.4% 352.45 US$3,551,110
2024-12-18 2024-12-17 B Purchase
55,515 +17.2%
159.40
US$4,588,313
55,515 +17.2% 159.40 US$4,588,313
2024-12-18 2024-12-16 B Purchase
27,931 -0.8%
182.12
US$989,865
27,931 -0.8% 182.12 US$989,865
2022-09-19 2022-09-16 B Purchase
30,000 +100.0%
1.56
US$46,710
30,000 +100.0% 1.56 US$46,710
2021-09-13 2021-09-10 B Purchase
5,000 +20.0%
6.32
US$31,600
5,000 +20.0% 6.32 US$31,600
2021-09-13 2021-09-10 B Purchase
5,000 +25.0%
6.35
US$31,750
5,000 +25.0% 6.35 US$31,750
2021-09-13 2021-09-10 B Purchase
10,000 +100.0%
6.38
US$63,800
10,000 +100.0% 6.38 US$63,800
2021-09-13 2021-09-10 B Purchase
5,000 +100.0%
6.75
US$33,750
5,000 +100.0% 6.75 US$33,750
2021-09-13 2021-09-10 B Purchase
5,000 +inf%
6.62
US$33,100
5,000 +inf% 6.62 US$33,100
2020-11-12 2020-11-10 B Purchase
50,000 +inf%
2.01
US$100,720
50,000 +inf% 2.01 US$100,720
2019-09-26 2019-09-24 B Purchase
30,000 +17.1%
1.91
US$57,240
30,000 +17.1% 1.91 US$57,240